Current controversies in the management of idiopathic thrombocytopenic purpura during childhood

被引：60

作者：

Medeiros, D

Buchanan, GR

机构：

[1] UNIV TEXAS, SW MED CTR, DEPT PEDIAT, DIV HEMATOL ONCOL, DALLAS, TX 75235 USA

[2] CHILDRENS MED CTR, DALLAS, TX 75235 USA

[3] CTR CANC & BLOOD DISORDERS, DALLAS, TX USA

来源：

PEDIATRIC CLINICS OF NORTH AMERICA | 1996年 / 43卷 / 03期

关键词：

D O I：

10.1016/S0031-3955(05)70431-4

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

Idiopathic thrombocytopenic purpura is one of the more common acquired bleeding disorders encountered by pediatricians. Despite numerous studies of possible therapeutic options for this disorder, ongoing controversy exists regarding the management of affected children. This article reviews the presentation and diagnosis of idiopathic thrombocytopenic purpura and discusses three subjects relevant to its treatment and prognosis: (1) multicenter randomized clinical trials aimed at defining the most rapid means of raising the platelet count in acute idiopathic thrombocytopenic purpura; (2) the frequency of and risk factors for intracranial hemorrhage; and (3) the natural history of chronic idiopathic thrombocytopenic purpura during childhood.

引用

收藏

页码：757 / +

页数：1

相关论文

共 66 条

[1] LONG-TERM FOLLOW-UP-STUDY OF CHILDREN WITH CHRONIC ITP [J].

AKATSUKA, J ;

FUJISAWA, K ;

ISHIDOYA, N ;

TAGUCHI, N ;

TSUKIMOTO, I ;

TSUJINO, G ;

NAGAO, T ;

NAKAHATA, T ;

MIYAZAKI, S ;

TAKEDA, T ;

AKABANE, T .

BLUT, 1989, 59 (01) :105-108

[2] ACUTE IMMUNE THROMBOCYTOPENIC PURPURA - A COMPARATIVE-STUDY OF VERY HIGH ORAL DOSES OF METHYLPREDNISOLONE AND INTRAVENOUSLY ADMINISTERED IMMUNE GLOBULIN [J].

ALBAYRAK, D ;

ISLEK, I ;

KALAYCI, AG ;

GURSES, N .

JOURNAL OF PEDIATRICS, 1994, 125 (06) :1004-1007

[3] 17 YEARS OF EXPERIENCE WITH CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDHOOD - IS THERAPY ALWAYS BETTER [J].

ARONIS, S ;

PLATOKOUKI, H ;

MITSIKA, A ;

HAIDAS, S ;

CONSTANTOPOULOS, A .

PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1994, 11 (05) :487-498

[4]

BARRIOS NJ, 1993, ACTA HAEMATOL-BASEL, V89, P6

[5] RANDOMIZED TRIAL OF INTRAVENOUS IMMUNOGLOBULIN-G, INTRAVENOUS ANTI-D, AND ORAL PREDNISONE IN CHILDHOOD ACUTE IMMUNE THROMBOCYTOPENIC PURPURA [J].

BLANCHETTE, V ;

IMBACH, P ;

ANDREW, M ;

ADAMS, M ;

MCMILLAN, J ;

WANG, E ;

MILNER, R ;

ALI, K ;

BARNARD, D ;

BERNSTEIN, M ;

CHAN, KW ;

ESSELTINE, D ;

DEVEBER, B ;

ISRAELS, S ;

KOBRINSKY, N ;

LUKE, B .

LANCET, 1994, 344 (8924) :703-707

[6]

BLANCHETTE VS, 1986, J PEDIATR-US, V108, P326, DOI 10.1016/S0022-3476(86)81014-9

[7] A PROSPECTIVE, RANDOMIZED TRIAL OF HIGH-DOSE INTRAVENOUS IMMUNE GLOBULIN G THERAPY, ORAL PREDNISONE THERAPY, AND NO THERAPY IN CHILDHOOD ACUTE IMMUNE THROMBOCYTOPENIC PURPURA [J].

BLANCHETTE, VS ;

LUKE, B ;

ANDREW, M ;

SOMMERVILLENIELSEN, S ;

BARNARD, D ;

DEVEBER, B ;

GENT, M .

JOURNAL OF PEDIATRICS, 1993, 123 (06) :989-995

[8] SPONTANEOUS INTRACRANIAL HEMORRHAGE IN IMMUNE THROMBOCYTOPENIC PURPURA [J].

BRENNER, B ;

GUILBURD, JN ;

TATARSKY, I ;

DORON, Y ;

GOLDSHER, D .

NEUROSURGERY, 1988, 22 (04) :761-764

[9] THE NONTREATMENT OF CHILDHOOD IDIOPATHIC THROMBOCYTOPENIC PURPURA [J].

BUCHANAN, GR .

EUROPEAN JOURNAL OF PEDIATRICS, 1987, 146 (02) :107-112

[10] OVERVIEW OF ITP TREATMENT MODALITIES IN CHILDREN [J].

BUCHANAN, GR .

BLUT, 1989, 59 (01) :96-104

← 1 2 3 4 5 6 7 →